Sponsor or institution
Clinical trials and research at Seagen Inc.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Seagen Inc. that are recruiting, at sites in 28 countries (most in Spain (5), United Kingdom (5), United States (5)). By phase: Phase 1 (3), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 28Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Testing a new drug for adults with advanced solid tumors | Phase 1 | Phoenix, Arizona and 47 other locations | Recruiting | Nov 14, 2023 |
| Combination treatment for HER2 positive metastatic colorectal cancer | Phase 3 | Glendale, Arizona and 365 other locations | Recruiting | Feb 24, 2022 |
| Testing a new drug for advanced solid tumors | Phase 1 | Birmingham, Alabama and 61 other locations | Recruiting | Jan 26, 2022 |
| Treatment of HER2 expressing urothelial cancer with disitamab vedotin and pembrolizumab | Phase 2 | Gilbert, Arizona and 220 other locations | Recruiting | May 10, 2021 |
| Testing a new drug for advanced solid tumors | Phase 1 | Anchorage, Alaska and 157 other locations | Recruiting | May 15, 2020 |
All recruiting trials (5)
-
Testing a new drug for adults with advanced solid tumors
This study is testing a new drug for adults with advanced solid tumors that haven't responded to other treatments to see if it can help them.
-
Combination treatment for HER2 positive metastatic colorectal cancer
This study is testing a new combination of tucatinib, trastuzumab, and mFOLFOX6 to see if it helps people with HER2 positive metastatic colorectal cancer more than the usual treatments.
-
Testing a new drug for advanced solid tumors
This study is testing a new drug for people with advanced solid tumors, like lung and head and neck cancers, to see if it works better when combined with another treatment after other options have failed.
-
Treatment of HER2 expressing urothelial cancer with disitamab vedotin and pembrolizumab
This study is testing if a new drug called disitamab vedotin, alone or with another drug called pembrolizumab, can help shrink tumors in patients with a specific type of bladder cancer that can't be surgically removed.
-
Testing a new drug for advanced solid tumors
This study is testing a new drug called sigvotatug vedotin to see if it can safely help people with advanced solid tumors, both on its own and with other treatments.
Quick answers
How many clinical trials run by Seagen Inc. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 28 countries. The most sites are in Spain (5 trials), United Kingdom (5 trials), United States (5 trials), France (4 trials), Canada (4 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.